36.46
-0.10
(-0.27%)
At close: January 10 at 3:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | 2.72 | 3.01 |
| Low Estimate | 0 | 0 | 2.65 | 3 |
| High Estimate | 0 | 0 | 2.8 | 3.01 |
| Year Ago EPS | -- | -- | 2.7 | 2.72 |
Revenue Estimate
| Currency in CHF | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 15 | 16 |
| Avg. Estimate | 14.91B | 15.4B | 60.76B | 64.13B |
| Low Estimate | 14.82B | 15.4B | 60.02B | 62.1B |
| High Estimate | 15.07B | 15.41B | 62.19B | 66.23B |
| Year Ago Sales | 14.27B | 14.66B | 58.72B | 60.76B |
| Sales Growth (year/est) | 4.48% | 5.06% | 3.48% | 5.55% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 2.72 | 3.01 |
| 7 Days Ago | 0 | 0 | 2.72 | 3.01 |
| 30 Days Ago | 0 | 0 | 2.75 | 3.04 |
| 60 Days Ago | 0 | 0 | 2.75 | 3.04 |
| 90 Days Ago | 0 | 0 | 2.78 | 3.06 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RHHBY | -- | -- | 0.70% | 10.41% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Maintains | TD Cowen: Market Perform to Market Perform | 9/12/2023 |
| Downgrade | Cowen & Co.: Outperform to Market Perform | 11/15/2022 |
| Maintains | Cowen & Co.: Outperform | 6/27/2022 |
| Upgrade | Deutsche Bank: Hold to Buy | 7/8/2021 |
| Initiated | Argus Research: Buy | 1/28/2019 |
| Upgrade | Credit Suisse: Underperform to Neutral | 1/28/2019 |
Related Tickers
SNY Sanofi
48.73
-1.02%
NVS Novartis AG
99.08
-1.14%
GSK GSK plc
33.09
-1.96%
AZN AstraZeneca PLC
67.01
+0.65%
BAYRY Bayer Aktiengesellschaft
5.12
+0.99%
AMGN Amgen Inc.
262.23
-0.75%
BMY Bristol-Myers Squibb Company
55.83
-1.73%
GILD Gilead Sciences, Inc.
89.88
+0.83%
BIIB Biogen Inc.
148.82
-1.28%
MRK Merck & Co., Inc.
99.25
-0.60%